Company Info
| Phone: | (617) 607-0800 |
| Year Established: | 1998 |
| Ticker: | ENTA |
| Exchange: | NASDAQ |
Contacts
| Primary: | Jay R. Luly, Ph.D. President & CEO |
| Other: | Yat Sun Or, Ph.D. Senior VP, R&D & CSO Paul J. Mellett CFO Scott T. Rottinghaus, M.D. CMO Nathaniel S. Gardiner, J.D. General Counsel Tara L. Kieffer, Ph.D. Senior VP, New Product Strategy and Development Brendan Luu Senior VP, Business Development |
Company Description
Enantaﾒs chemistry-driven approach and drug discovery capabilities are focused on small molecule drugs for the treatment of viral infections and liver diseases.
